Advertisement for orthosearch.org.uk
Results 1 - 7 of 7
Results per page:
The Journal of Bone & Joint Surgery British Volume
Vol. 72-B, Issue 6 | Pages 959 - 965
1 Nov 1990
Kavanagh T Cannon Pringle J Stoker D Kemp H

We have reviewed 20 cases of parosteal osteosarcoma treated by wide local resection and prosthetic replacement and followed up for six to 17 years. Limb function was excellent in 85%. One patient with grade III histological disease developed pulmonary metastases. Four patients had local recurrences, which were related to repeated preliminary biopsies, inappropriate siting of biopsy and vascular encroachment by the tumour. After this mode of treatment, the outcome was not related to medullary invasion by the tumour.


The Journal of Bone & Joint Surgery British Volume
Vol. 72-B, Issue 5 | Pages 921 - 921
1 Sep 1990
Kemp H


The Journal of Bone & Joint Surgery British Volume
Vol. 69-B, Issue 4 | Pages 551 - 555
1 Aug 1987
Calvert P August A Albert J Kemp H Catterall A

We report the clinical and radiographic results of the Chiari pelvic osteotomy in 49 hips (45 patients) at an average of 14 years after operation. Of these hips, over half had minimal or no pain, had good or excellent results as assessed by the Harris hip score, and could walk at least three miles; three-quarters, however, had a positive Trendelenburg sign. A younger age at operation and a painless hip with no radiographic evidence of degeneration before operation were associated with a higher hip score at review. The percentage of hips without degenerative changes fell from 68% before operation to 15% at final review. There were no major complications and it was found that a Chiari osteotomy need not interfere with normal childbirth.


The Journal of Bone & Joint Surgery British Volume
Vol. 69-B, Issue 2 | Pages 276 - 284
1 Mar 1987
Bradish C Kemp H Scales J Wilson J

We report the long-term clinical follow-up and survivorship analysis of 40 distal femoral replacements performed between 1964 and 1980 for traumatic, locally aggressive and malignant conditions. Custom-made prostheses with fully-constrained knee joints were used to replace a mean of 42% of the length of the femur. Survivorship analysis showed a cumulative success rate of 80% at eight years, with no subsequent deterioration at 18 years. Clinical assessment revealed 78% excellent or good results. Failure was due to infection in three cases, and in two to fracture of a now-outmoded femoral stem.


The Journal of Bone & Joint Surgery British Volume
Vol. 64-B, Issue 3 | Pages 276 - 281
1 Jun 1982
Catterall A Pringle J Byers P Fulford G Kemp H


The Journal of Bone & Joint Surgery British Volume
Vol. 64-B, Issue 3 | Pages 269 - 275
1 Jun 1982
Catterall A Pringle J Byers P Fulford G Kemp H Dolman C Bell H McKibbin B Ralis Z Jensen O Lauritzen J Ponseti I Ogden J

There are differences of opinion about the pathogenesis of Perthes' disease. All are agreed that it is due to ischaemia, but the cause of this and the size and number of infarctions are in dispute. Through the generosity of the contributors six whole femoral heads and core biopsies of five other cases have been studied radiographically and histologically. The findings ranged from an ischaemic arrest of ossification in the capital articular cartilage without infarction to multiple complete infarctions of the epiphysial bone. The ensuing reparative process contributes to the pathology, which is of a range to warrant grading or grouping.


The Journal of Bone & Joint Surgery British Volume
Vol. 63-B, Issue 2 | Pages 219 - 224
1 May 1981
Dobbs H Scales J Wilson J Kemp H Burrows H Sneath R

A series of 81 patients has been reviewed to determine the value of endoprosthetic replacement of the proximal femur and hip in the treatment of bone tumours. Standard statistical methods were used to evaluate the survival of the replacements and the patients. Taking removal of the prosthesis, irrespective of the cause, as the criterion for failure the survival of the replacements was found to be 63 per cent after 10 years. If deaths are regarded as failures, then the survival value falls to 48 per cent. The survival of patients with chondrosarcoma and osteoclastoma treated by endoprosthetic replacement compares favourably with survival after amputation or excision of the tumour.